Stuart Nayman is a partner in the Corporate Practice Group. He joined the firm in 2000 after seven years of practice at another New York City law firm.
Practice
Mr. Nayman's practice focuses on corporate and securities law, with an emphasis on public offerings, mergers and acquisitions and public company representation. He has extensive experience in representing issuers and underwriters in capital market transactions, including initial public offerings, follow-on equity offerings, convertible debt offerings and PIPE transactions. Mr. Nayman's transactional experience also includes venture capital transactions. A significant portion of his practice involves counseling public companies on ongoing corporate legal matters, including federal securities law reporting requirements and corporate governance matters. Mr. Nayman's clients include investment banks, venture capital firms and public and private companies in the life sciences, software and information technology industries.
Recent Highlights
Representation of:
- Arlington Tankers Ltd. in its merger with General Maritime Corporation
- Biodel Inc. in its follow-on public offering
- Eyetech Pharmaceuticals, Inc. in its initial public offering and its sale to OSI Pharmaceuticals, Inc.
- Lincare Holdings Inc. and Amdocs Inc. in Rule 144A offerings of convertible notes
- Morgan Stanley as lead underwriter in public offerings for Barrier Therapeutics, Inc.; BioCryst Pharmaceuticals, Inc.; Biodel Inc.; Cubist Pharmaceuticals, Inc.; Vicuron Pharmaceuticals, Inc.; and Visicu, Inc.
- Goldman, Sachs & Co. as lead underwriter in public offerings for Alexion Pharmaceuticals, Inc.; Cubist Pharmaceuticals, Inc.; Evercore Partners Inc.; and Fisher Scientific International Inc.
- Banc of America Securities as lead underwriter in a public offering for Pharmion Corporation
- Deutsche Bank Securities as lead underwriter in the initial public offering and follow-on public offerings of Targacept, Inc.
- JPMorgan as lead underwriter in public offerings for AstroPower, Inc. and Plug Power, Inc.
- PTC Therapeutics, Inc.; Intercept Pharmaceuticals, Inc.; Partsearch Technologies, Inc.; Flexplay Technologies, Inc.; Evident Software, Inc. and other private companies in various venture capital financings
Publications
- Becker, Brandon, Andre Owens, Stuart R. Nayman, Jerome Roche, and Jaime Klima. "SEC, NYSE and NASD Propose Rules for Allocation and Distribution of Offering Shares." WilmerHale Securities Law Update (January 2005).
- Falber, Stuart, Andrew Gilbert, Stuart R. Nayman, and Belinda Juran. "Preparing To Go Public: Practical Insights for Biotech Companies." J. Biolaw & Bus. 7, No. 4 (2004).
